84.50 USD
▲-0.26+3.06%
盘后 81.50 -0.60%
2026-08-03
市值
$276.21M
市盈率
—
EPS
-0.37
股息率
—
52 周区间
12.50 – 97.97
成交量
40.09K
Beta
1.16
目标价
193.00
52W 低 12.5052W 高 97.97
价格走势
公司简介
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-...